Deutsche Bank
ICVX

Deutsche Bank’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Deutsche Bank’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,003
Closed -$173K – 3708
2023
Q4 		$173K Buy
11,003
+349
+3% +$3.36K ﹤0.01% 2946
2023
Q3 		$82.6K Hold
10,654
– – ﹤0.01% 3245
2023
Q2 		$106K Sell
10,654
-3,467
-25% -$27.8K ﹤0.01% 3252
2023
Q1 		$81.9K Buy
14,121
+3,837
+37% +$33.1K ﹤0.01% 3409
2022
Q4 		$81.7K Buy
10,284
+150
+1% +$644 ﹤0.01% 3424
2022
Q3 		$32K Sell
10,134
-1,490
-13% -$9.32K ﹤0.01% 3695
2022
Q2 		$67K Sell
11,624
-2,099
-15% -$16.4K ﹤0.01% 3674
2022
Q1 		$96K Buy
13,723
+5,146
+60% +$80.9K ﹤0.01% 3595
2021
Q4 		$196K Buy
8,577
+430
+5% +$11.1K ﹤0.01% 3398
2021
Q3 		$241K Buy
+8,147
New +$276K ﹤0.01% 3472

Deutsche Bank's ICVX Position: Q1 2024 in Review

Deutsche Bank sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 11,003 shares — an estimated $173K sold.

Deutsche Bank first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $241K in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Deutsche Bank reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 11,003 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $173K.
  • Deutsche Bank first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Deutsche Bank's Icosavax, Inc. Common Stock position peaked at $241K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.